ArticleJournal of thoracic disease2024
17-hydroxy-jolkinolide B potentiated CTLA4ab therapy through targeting tumor suppression and immune activation by downregulating PD-L1 expression in lung adenocarcinoma.
Xuewei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.